nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0225	0.0311	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0225	0.0311	CbGbCtD
Pimozide—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0194	0.0269	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0194	0.0269	CbGbCtD
Pimozide—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0188	0.0261	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0188	0.0261	CbGbCtD
Pimozide—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0186	0.0258	CbGbCtD
Pimozide—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.017	0.0236	CbGbCtD
Pimozide—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.017	0.0236	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.017	0.0236	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.017	0.0236	CbGbCtD
Pimozide—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0169	0.0233	CbGbCtD
Pimozide—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0169	0.0233	CbGbCtD
Pimozide—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0164	0.0228	CbGbCtD
Pimozide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.016	0.0221	CbGbCtD
Pimozide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.015	0.0208	CbGbCtD
Pimozide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0148	0.0204	CbGbCtD
Pimozide—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0146	0.0201	CbGbCtD
Pimozide—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0141	0.0196	CbGbCtD
Pimozide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0139	0.0192	CbGbCtD
Pimozide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0139	0.0192	CbGbCtD
Pimozide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0136	0.0188	CbGbCtD
Pimozide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0136	0.0188	CbGbCtD
Pimozide—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0128	0.0177	CbGbCtD
Pimozide—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0128	0.0177	CbGbCtD
Pimozide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0125	0.0174	CbGbCtD
Pimozide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0122	0.0168	CbGbCtD
Pimozide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0121	0.0168	CbGbCtD
Pimozide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0117	0.0162	CbGbCtD
Pimozide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0114	0.0158	CbGbCtD
Pimozide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0114	0.0158	CbGbCtD
Pimozide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0114	0.0158	CbGbCtD
Pimozide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.011	0.0152	CbGbCtD
Pimozide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0105	0.0146	CbGbCtD
Pimozide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0103	0.0143	CbGbCtD
Pimozide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0103	0.0143	CbGbCtD
Pimozide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0103	0.0143	CbGbCtD
Pimozide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0103	0.0143	CbGbCtD
Pimozide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00988	0.0137	CbGbCtD
Pimozide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00951	0.0132	CbGbCtD
Pimozide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00947	0.0131	CbGbCtD
Pimozide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00919	0.0127	CbGbCtD
Pimozide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00892	0.0124	CbGbCtD
Pimozide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00866	0.012	CbGbCtD
Pimozide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00831	0.0115	CbGbCtD
Pimozide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00831	0.0115	CbGbCtD
Pimozide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00797	0.011	CbGbCtD
Pimozide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00783	0.0108	CbGbCtD
Pimozide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00783	0.0108	CbGbCtD
Pimozide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00773	0.0107	CbGbCtD
Pimozide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00727	0.0101	CbGbCtD
Pimozide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00727	0.0101	CbGbCtD
Pimozide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00657	0.0091	CbGbCtD
Pimozide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00657	0.0091	CbGbCtD
Pimozide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00617	0.00854	CbGbCtD
Pimozide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00567	0.00786	CbGbCtD
Pimozide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00551	0.00763	CbGbCtD
Pimozide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00498	0.0069	CbGbCtD
Pimozide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00498	0.0069	CbGbCtD
Pimozide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00478	0.00661	CbGbCtD
Pimozide—CALM2—semen—acquired immunodeficiency syndrome	0.00288	0.0429	CbGeAlD
Pimozide—CALM1—semen—acquired immunodeficiency syndrome	0.00286	0.0427	CbGeAlD
Pimozide—OPRM1—nerve—acquired immunodeficiency syndrome	0.00191	0.0285	CbGeAlD
Pimozide—CALM2—nerve—acquired immunodeficiency syndrome	0.00139	0.0207	CbGeAlD
Pimozide—CALM1—nerve—acquired immunodeficiency syndrome	0.00138	0.0206	CbGeAlD
Pimozide—DRD2—nerve—acquired immunodeficiency syndrome	0.00127	0.019	CbGeAlD
Pimozide—CACNA1G—digestive system—acquired immunodeficiency syndrome	0.00123	0.0183	CbGeAlD
Pimozide—CALM2—endothelium—acquired immunodeficiency syndrome	0.00118	0.0176	CbGeAlD
Pimozide—CALM1—endothelium—acquired immunodeficiency syndrome	0.00117	0.0175	CbGeAlD
Pimozide—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00107	0.0159	CbGeAlD
Pimozide—CALM2—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0156	CbGeAlD
Pimozide—CALM1—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0156	CbGeAlD
Pimozide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000995	0.0149	CbGeAlD
Pimozide—CACNA1G—nervous system—acquired immunodeficiency syndrome	0.000951	0.0142	CbGeAlD
Pimozide—CACNA1G—central nervous system—acquired immunodeficiency syndrome	0.000915	0.0137	CbGeAlD
Pimozide—HTR2A—nerve—acquired immunodeficiency syndrome	0.000841	0.0125	CbGeAlD
Pimozide—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000813	0.0121	CbGeAlD
Pimozide—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000784	0.0117	CbGeAlD
Pimozide—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000731	0.0109	CbGeAlD
Pimozide—CALM3—retina—acquired immunodeficiency syndrome	0.000731	0.0109	CbGeAlD
Pimozide—CACNA1G—brain—acquired immunodeficiency syndrome	0.000727	0.0108	CbGeAlD
Pimozide—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000716	0.0107	CbGeAlD
Pimozide—DRD3—nervous system—acquired immunodeficiency syndrome	0.000678	0.0101	CbGeAlD
Pimozide—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000652	0.00974	CbGeAlD
Pimozide—HTR6—nervous system—acquired immunodeficiency syndrome	0.000652	0.00973	CbGeAlD
Pimozide—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000636	0.00949	CbGeAlD
Pimozide—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000628	0.00937	CbGeAlD
Pimozide—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000604	0.00901	CbGeAlD
Pimozide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000588	0.00878	CbGeAlD
Pimozide—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000581	0.00868	CbGeAlD
Pimozide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000579	0.00864	CbGeAlD
Pimozide—CALM2—retina—acquired immunodeficiency syndrome	0.000574	0.00857	CbGeAlD
Pimozide—CALM1—retina—acquired immunodeficiency syndrome	0.000571	0.00853	CbGeAlD
Pimozide—OPRM1—blood—acquired immunodeficiency syndrome	0.000529	0.0079	CbGeAlD
Pimozide—DRD2—retina—acquired immunodeficiency syndrome	0.000528	0.00788	CbGeAlD
Pimozide—DRD3—brain—acquired immunodeficiency syndrome	0.000518	0.00773	CbGeAlD
Pimozide—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.00051	0.00761	CbGeAlD
Pimozide—CALM2—skin of body—acquired immunodeficiency syndrome	0.000504	0.00752	CbGeAlD
Pimozide—CALM1—skin of body—acquired immunodeficiency syndrome	0.000502	0.00749	CbGeAlD
Pimozide—HTR6—brain—acquired immunodeficiency syndrome	0.000499	0.00744	CbGeAlD
Pimozide—CALM3—blood—acquired immunodeficiency syndrome	0.000489	0.0073	CbGeAlD
Pimozide—CALM3—bone marrow—acquired immunodeficiency syndrome	0.000473	0.00706	CbGeAlD
Pimozide—CALM3—spinal cord—acquired immunodeficiency syndrome	0.000471	0.00703	CbGeAlD
Pimozide—OPRK1—brain—acquired immunodeficiency syndrome	0.000462	0.00689	CbGeAlD
Pimozide—CALM3—vagina—acquired immunodeficiency syndrome	0.000453	0.00677	CbGeAlD
Pimozide—OPRM1—nervous system—acquired immunodeficiency syndrome	0.00043	0.00641	CbGeAlD
Pimozide—CALM3—lung—acquired immunodeficiency syndrome	0.000429	0.0064	CbGeAlD
Pimozide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000417	0.00622	CbGeAlD
Pimozide—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.000414	0.00617	CbGeAlD
Pimozide—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000408	0.00609	CbGeAlD
Pimozide—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000406	0.00606	CbGeAlD
Pimozide—CALM2—digestive system—acquired immunodeficiency syndrome	0.000403	0.00602	CbGeAlD
Pimozide—CALM1—digestive system—acquired immunodeficiency syndrome	0.000401	0.00599	CbGeAlD
Pimozide—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000391	0.00584	CbGeAlD
Pimozide—CALM2—blood—acquired immunodeficiency syndrome	0.000384	0.00573	CbGeAlD
Pimozide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000383	0.00571	CbGeAlD
Pimozide—CALM1—blood—acquired immunodeficiency syndrome	0.000382	0.00571	CbGeAlD
Pimozide—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000376	0.00562	CbGeAlD
Pimozide—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000376	0.00562	CbGeAlD
Pimozide—CALM2—bone marrow—acquired immunodeficiency syndrome	0.000372	0.00555	CbGeAlD
Pimozide—CALM2—spinal cord—acquired immunodeficiency syndrome	0.00037	0.00552	CbGeAlD
Pimozide—CALM1—bone marrow—acquired immunodeficiency syndrome	0.00037	0.00552	CbGeAlD
Pimozide—CALM1—spinal cord—acquired immunodeficiency syndrome	0.000368	0.0055	CbGeAlD
Pimozide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000365	0.00544	CbGeAlD
Pimozide—CALM2—vagina—acquired immunodeficiency syndrome	0.000356	0.00531	CbGeAlD
Pimozide—CALM1—vagina—acquired immunodeficiency syndrome	0.000354	0.00529	CbGeAlD
Pimozide—HTR2A—retina—acquired immunodeficiency syndrome	0.000348	0.0052	CbGeAlD
Pimozide—KCNH2—blood—acquired immunodeficiency syndrome	0.000348	0.00519	CbGeAlD
Pimozide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000338	0.00505	CbGeAlD
Pimozide—CALM2—lung—acquired immunodeficiency syndrome	0.000337	0.00502	CbGeAlD
Pimozide—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000337	0.00502	CbGeAlD
Pimozide—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000335	0.005	CbGeAlD
Pimozide—CALM1—lung—acquired immunodeficiency syndrome	0.000335	0.005	CbGeAlD
Pimozide—OPRM1—brain—acquired immunodeficiency syndrome	0.000328	0.0049	CbGeAlD
Pimozide—KCNH2—vagina—acquired immunodeficiency syndrome	0.000322	0.00481	CbGeAlD
Pimozide—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000317	0.00473	CbGeAlD
Pimozide—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000313	0.00467	CbGeAlD
Pimozide—CALM2—nervous system—acquired immunodeficiency syndrome	0.000312	0.00465	CbGeAlD
Pimozide—CALM1—nervous system—acquired immunodeficiency syndrome	0.00031	0.00463	CbGeAlD
Pimozide—DRD2—lung—acquired immunodeficiency syndrome	0.00031	0.00462	CbGeAlD
Pimozide—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000305	0.00456	CbGeAlD
Pimozide—CALM3—brain—acquired immunodeficiency syndrome	0.000303	0.00453	CbGeAlD
Pimozide—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000302	0.0045	CbGeAlD
Pimozide—CALM2—central nervous system—acquired immunodeficiency syndrome	0.0003	0.00448	CbGeAlD
Pimozide—CHRM2—brain—acquired immunodeficiency syndrome	0.000299	0.00446	CbGeAlD
Pimozide—CALM1—central nervous system—acquired immunodeficiency syndrome	0.000299	0.00446	CbGeAlD
Pimozide—CYP1A2—blood—acquired immunodeficiency syndrome	0.000298	0.00445	CbGeAlD
Pimozide—CALM3—lymph node—acquired immunodeficiency syndrome	0.000293	0.00438	CbGeAlD
Pimozide—HRH1—digestive system—acquired immunodeficiency syndrome	0.000293	0.00437	CbGeAlD
Pimozide—CYP3A5—blood—acquired immunodeficiency syndrome	0.000287	0.00429	CbGeAlD
Pimozide—DRD2—nervous system—acquired immunodeficiency syndrome	0.000287	0.00428	CbGeAlD
Pimozide—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000285	0.00425	CbGeAlD
Pimozide—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000282	0.00422	CbGeAlD
Pimozide—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000281	0.0042	CbGeAlD
Pimozide—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000276	0.00412	CbGeAlD
Pimozide—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000272	0.00406	CbGeAlD
Pimozide—CYP2E1—blood—acquired immunodeficiency syndrome	0.000268	0.004	CbGeAlD
Pimozide—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000266	0.00397	CbGeAlD
Pimozide—CYP1A2—lung—acquired immunodeficiency syndrome	0.000261	0.0039	CbGeAlD
Pimozide—HRH1—vagina—acquired immunodeficiency syndrome	0.000258	0.00386	CbGeAlD
Pimozide—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000258	0.00385	CbGeAlD
Pimozide—CYP3A5—lung—acquired immunodeficiency syndrome	0.000252	0.00376	CbGeAlD
Pimozide—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000244	0.00365	CbGeAlD
Pimozide—HRH1—lung—acquired immunodeficiency syndrome	0.000244	0.00365	CbGeAlD
Pimozide—HTR1A—brain—acquired immunodeficiency syndrome	0.000242	0.00362	CbGeAlD
Pimozide—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.0015	CcSEcCtD
Pimozide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00024	0.00149	CcSEcCtD
Pimozide—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00149	CcSEcCtD
Pimozide—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00149	CcSEcCtD
Pimozide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00149	CcSEcCtD
Pimozide—CALM2—brain—acquired immunodeficiency syndrome	0.000238	0.00356	CbGeAlD
Pimozide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000238	0.00148	CcSEcCtD
Pimozide—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00148	CcSEcCtD
Pimozide—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00148	CcSEcCtD
Pimozide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000238	0.00148	CcSEcCtD
Pimozide—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.00148	CcSEcCtD
Pimozide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000237	0.00148	CcSEcCtD
Pimozide—Shock—Indinavir—acquired immunodeficiency syndrome	0.000237	0.00147	CcSEcCtD
Pimozide—CALM1—brain—acquired immunodeficiency syndrome	0.000237	0.00354	CbGeAlD
Pimozide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000237	0.00147	CcSEcCtD
Pimozide—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00147	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00147	CcSEcCtD
Pimozide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000236	0.00147	CcSEcCtD
Pimozide—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.00147	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00147	CcSEcCtD
Pimozide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000235	0.00146	CcSEcCtD
Pimozide—CYP2E1—lung—acquired immunodeficiency syndrome	0.000235	0.00351	CbGeAlD
Pimozide—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00146	CcSEcCtD
Pimozide—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.00146	CcSEcCtD
Pimozide—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000234	0.00146	CcSEcCtD
Pimozide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000233	0.00145	CcSEcCtD
Pimozide—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00145	CcSEcCtD
Pimozide—HTR2A—blood—acquired immunodeficiency syndrome	0.000233	0.00348	CbGeAlD
Pimozide—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00145	CcSEcCtD
Pimozide—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00144	CcSEcCtD
Pimozide—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.00144	CcSEcCtD
Pimozide—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00143	CcSEcCtD
Pimozide—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000231	0.00143	CcSEcCtD
Pimozide—CALM2—lymph node—acquired immunodeficiency syndrome	0.00023	0.00344	CbGeAlD
Pimozide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00143	CcSEcCtD
Pimozide—CALM1—lymph node—acquired immunodeficiency syndrome	0.000229	0.00342	CbGeAlD
Pimozide—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00142	CcSEcCtD
Pimozide—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00142	CcSEcCtD
Pimozide—ABCB1—retina—acquired immunodeficiency syndrome	0.000228	0.0034	CbGeAlD
Pimozide—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.00141	CcSEcCtD
Pimozide—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.00141	CcSEcCtD
Pimozide—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00141	CcSEcCtD
Pimozide—HRH1—nervous system—acquired immunodeficiency syndrome	0.000226	0.00338	CbGeAlD
Pimozide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000226	0.00338	CbGeAlD
Pimozide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.0014	CcSEcCtD
Pimozide—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000224	0.00335	CbGeAlD
Pimozide—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00139	CcSEcCtD
Pimozide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000224	0.00139	CcSEcCtD
Pimozide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00139	CcSEcCtD
Pimozide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00139	CcSEcCtD
Pimozide—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00138	CcSEcCtD
Pimozide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000223	0.00332	CbGeAlD
Pimozide—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00138	CcSEcCtD
Pimozide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00138	CcSEcCtD
Pimozide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.00138	CcSEcCtD
Pimozide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000222	0.00138	CcSEcCtD
Pimozide—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00138	CcSEcCtD
Pimozide—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.00138	CcSEcCtD
Pimozide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00137	CcSEcCtD
Pimozide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00137	CcSEcCtD
Pimozide—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00137	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00137	CcSEcCtD
Pimozide—DRD2—brain—acquired immunodeficiency syndrome	0.000219	0.00327	CbGeAlD
Pimozide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000219	0.00136	CcSEcCtD
Pimozide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000218	0.00136	CcSEcCtD
Pimozide—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.00136	CcSEcCtD
Pimozide—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.00136	CcSEcCtD
Pimozide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000218	0.00136	CcSEcCtD
Pimozide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.00136	CcSEcCtD
Pimozide—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000218	0.00325	CbGeAlD
Pimozide—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000218	0.00325	CbGeAlD
Pimozide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00135	CcSEcCtD
Pimozide—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00135	CcSEcCtD
Pimozide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000217	0.00135	CcSEcCtD
Pimozide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000216	0.00135	CcSEcCtD
Pimozide—HTR2A—vagina—acquired immunodeficiency syndrome	0.000216	0.00322	CbGeAlD
Pimozide—KCNH2—brain—acquired immunodeficiency syndrome	0.000216	0.00322	CbGeAlD
Pimozide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000216	0.00322	CbGeAlD
Pimozide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000215	0.00134	CcSEcCtD
Pimozide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000215	0.00133	CcSEcCtD
Pimozide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00133	CcSEcCtD
Pimozide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00133	CcSEcCtD
Pimozide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000214	0.00133	CcSEcCtD
Pimozide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00133	CcSEcCtD
Pimozide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00133	CcSEcCtD
Pimozide—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00133	CcSEcCtD
Pimozide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00132	CcSEcCtD
Pimozide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00132	CcSEcCtD
Pimozide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00132	CcSEcCtD
Pimozide—CYP2D6—blood—acquired immunodeficiency syndrome	0.000212	0.00317	CbGeAlD
Pimozide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00132	CcSEcCtD
Pimozide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.00132	CcSEcCtD
Pimozide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000211	0.00131	CcSEcCtD
Pimozide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000211	0.00131	CcSEcCtD
Pimozide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000211	0.00131	CcSEcCtD
Pimozide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.00131	CcSEcCtD
Pimozide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00131	CcSEcCtD
Pimozide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00131	CcSEcCtD
Pimozide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00021	0.0013	CcSEcCtD
Pimozide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.0013	CcSEcCtD
Pimozide—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000209	0.00313	CbGeAlD
Pimozide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.0013	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.0013	CcSEcCtD
Pimozide—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000209	0.00311	CbGeAlD
Pimozide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000208	0.00129	CcSEcCtD
Pimozide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000208	0.00129	CcSEcCtD
Pimozide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00129	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00129	CcSEcCtD
Pimozide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000206	0.00128	CcSEcCtD
Pimozide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.00128	CcSEcCtD
Pimozide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.00128	CcSEcCtD
Pimozide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00128	CcSEcCtD
Pimozide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00128	CcSEcCtD
Pimozide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00128	CcSEcCtD
Pimozide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000205	0.00127	CcSEcCtD
Pimozide—HTR2A—lung—acquired immunodeficiency syndrome	0.000204	0.00305	CbGeAlD
Pimozide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000204	0.00127	CcSEcCtD
Pimozide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000204	0.00127	CcSEcCtD
Pimozide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.00127	CcSEcCtD
Pimozide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00126	CcSEcCtD
Pimozide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00126	CcSEcCtD
Pimozide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.00126	CcSEcCtD
Pimozide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00126	CcSEcCtD
Pimozide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00126	CcSEcCtD
Pimozide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000201	0.00125	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00125	CcSEcCtD
Pimozide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00124	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.00123	CcSEcCtD
Pimozide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.00123	CcSEcCtD
Pimozide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.00123	CcSEcCtD
Pimozide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00123	CcSEcCtD
Pimozide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.00123	CcSEcCtD
Pimozide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.00123	CcSEcCtD
Pimozide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000197	0.00123	CcSEcCtD
Pimozide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.00123	CcSEcCtD
Pimozide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00122	CcSEcCtD
Pimozide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00122	CcSEcCtD
Pimozide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00122	CcSEcCtD
Pimozide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000196	0.00122	CcSEcCtD
Pimozide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00122	CcSEcCtD
Pimozide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.00121	CcSEcCtD
Pimozide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00121	CcSEcCtD
Pimozide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.00121	CcSEcCtD
Pimozide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.00121	CcSEcCtD
Pimozide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000194	0.00121	CcSEcCtD
Pimozide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.0012	CcSEcCtD
Pimozide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.0012	CcSEcCtD
Pimozide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.0012	CcSEcCtD
Pimozide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.0012	CcSEcCtD
Pimozide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00119	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00119	CcSEcCtD
Pimozide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000192	0.00119	CcSEcCtD
Pimozide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00119	CcSEcCtD
Pimozide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00118	CcSEcCtD
Pimozide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00019	0.00118	CcSEcCtD
Pimozide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00019	0.00118	CcSEcCtD
Pimozide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.00118	CcSEcCtD
Pimozide—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000189	0.00282	CbGeAlD
Pimozide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00117	CcSEcCtD
Pimozide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.00117	CcSEcCtD
Pimozide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.00117	CcSEcCtD
Pimozide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.00117	CcSEcCtD
Pimozide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00117	CcSEcCtD
Pimozide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.00117	CcSEcCtD
Pimozide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000188	0.00117	CcSEcCtD
Pimozide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000188	0.00117	CcSEcCtD
Pimozide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.00117	CcSEcCtD
Pimozide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.00117	CcSEcCtD
Pimozide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000187	0.00116	CcSEcCtD
Pimozide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000187	0.00116	CcSEcCtD
Pimozide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.00116	CcSEcCtD
Pimozide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.00116	CcSEcCtD
Pimozide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000185	0.00115	CcSEcCtD
Pimozide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000185	0.00115	CcSEcCtD
Pimozide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00115	CcSEcCtD
Pimozide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000184	0.00114	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00114	CcSEcCtD
Pimozide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000184	0.00114	CcSEcCtD
Pimozide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00114	CcSEcCtD
Pimozide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.00113	CcSEcCtD
Pimozide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00113	CcSEcCtD
Pimozide—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000182	0.00272	CbGeAlD
Pimozide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00113	CcSEcCtD
Pimozide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00113	CcSEcCtD
Pimozide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.00113	CcSEcCtD
Pimozide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.00112	CcSEcCtD
Pimozide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00111	CcSEcCtD
Pimozide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00111	CcSEcCtD
Pimozide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.0011	CcSEcCtD
Pimozide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.0011	CcSEcCtD
Pimozide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000177	0.0011	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.0011	CcSEcCtD
Pimozide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.0011	CcSEcCtD
Pimozide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00109	CcSEcCtD
Pimozide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00109	CcSEcCtD
Pimozide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000175	0.00261	CbGeAlD
Pimozide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000175	0.00109	CcSEcCtD
Pimozide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00108	CcSEcCtD
Pimozide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.00108	CcSEcCtD
Pimozide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000173	0.00108	CcSEcCtD
Pimozide—HRH1—brain—acquired immunodeficiency syndrome	0.000173	0.00258	CbGeAlD
Pimozide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.00108	CcSEcCtD
Pimozide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00107	CcSEcCtD
Pimozide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.00107	CcSEcCtD
Pimozide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000172	0.00257	CbGeAlD
Pimozide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.00107	CcSEcCtD
Pimozide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000171	0.00106	CcSEcCtD
Pimozide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00105	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.00105	CcSEcCtD
Pimozide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000169	0.00251	CbGeAlD
Pimozide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00104	CcSEcCtD
Pimozide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00104	CcSEcCtD
Pimozide—HRH1—lymph node—acquired immunodeficiency syndrome	0.000167	0.0025	CbGeAlD
Pimozide—CYP2E1—brain—acquired immunodeficiency syndrome	0.000166	0.00248	CbGeAlD
Pimozide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.00103	CcSEcCtD
Pimozide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000166	0.00247	CbGeAlD
Pimozide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000165	0.00103	CcSEcCtD
Pimozide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00102	CcSEcCtD
Pimozide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.00102	CcSEcCtD
Pimozide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.00102	CcSEcCtD
Pimozide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.00102	CcSEcCtD
Pimozide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.00102	CcSEcCtD
Pimozide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.00101	CcSEcCtD
Pimozide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000162	0.00242	CbGeAlD
Pimozide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.001	CcSEcCtD
Pimozide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.001	CcSEcCtD
Pimozide—ABCB1—digestive system—acquired immunodeficiency syndrome	0.00016	0.00239	CbGeAlD
Pimozide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000995	CcSEcCtD
Pimozide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000993	CcSEcCtD
Pimozide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000991	CcSEcCtD
Pimozide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000984	CcSEcCtD
Pimozide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000972	CcSEcCtD
Pimozide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000969	CcSEcCtD
Pimozide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000959	CcSEcCtD
Pimozide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000958	CcSEcCtD
Pimozide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000957	CcSEcCtD
Pimozide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000953	CcSEcCtD
Pimozide—ABCB1—blood—acquired immunodeficiency syndrome	0.000153	0.00228	CbGeAlD
Pimozide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000945	CcSEcCtD
Pimozide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000944	CcSEcCtD
Pimozide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000939	CcSEcCtD
Pimozide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000936	CcSEcCtD
Pimozide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000927	CcSEcCtD
Pimozide—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000148	0.0022	CbGeAlD
Pimozide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000914	CcSEcCtD
Pimozide—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000147	0.00219	CbGeAlD
Pimozide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.0009	CcSEcCtD
Pimozide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000899	CcSEcCtD
Pimozide—HTR2A—brain—acquired immunodeficiency syndrome	0.000145	0.00216	CbGeAlD
Pimozide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000896	CcSEcCtD
Pimozide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000893	CcSEcCtD
Pimozide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000892	CcSEcCtD
Pimozide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000143	0.00089	CcSEcCtD
Pimozide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000887	CcSEcCtD
Pimozide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000887	CcSEcCtD
Pimozide—ABCB1—vagina—acquired immunodeficiency syndrome	0.000141	0.00211	CbGeAlD
Pimozide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000865	CcSEcCtD
Pimozide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000862	CcSEcCtD
Pimozide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000857	CcSEcCtD
Pimozide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000854	CcSEcCtD
Pimozide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000854	CcSEcCtD
Pimozide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000853	CcSEcCtD
Pimozide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000849	CcSEcCtD
Pimozide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000841	CcSEcCtD
Pimozide—ABCB1—lung—acquired immunodeficiency syndrome	0.000134	0.002	CbGeAlD
Pimozide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000829	CcSEcCtD
Pimozide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000825	CcSEcCtD
Pimozide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000825	CcSEcCtD
Pimozide—CYP2D6—brain—acquired immunodeficiency syndrome	0.000132	0.00196	CbGeAlD
Pimozide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000814	CcSEcCtD
Pimozide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000805	CcSEcCtD
Pimozide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000798	CcSEcCtD
Pimozide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000797	CcSEcCtD
Pimozide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.00079	CcSEcCtD
Pimozide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000789	CcSEcCtD
Pimozide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000787	CcSEcCtD
Pimozide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000785	CcSEcCtD
Pimozide—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000124	0.00185	CbGeAlD
Pimozide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000767	CcSEcCtD
Pimozide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000761	CcSEcCtD
Pimozide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.00076	CcSEcCtD
Pimozide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.00076	CcSEcCtD
Pimozide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000756	CcSEcCtD
Pimozide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000744	CcSEcCtD
Pimozide—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000119	0.00178	CbGeAlD
Pimozide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000732	CcSEcCtD
Pimozide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000725	CcSEcCtD
Pimozide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000725	CcSEcCtD
Pimozide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000721	CcSEcCtD
Pimozide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000716	CcSEcCtD
Pimozide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000683	CcSEcCtD
Pimozide—ABCB1—brain—acquired immunodeficiency syndrome	9.47e-05	0.00141	CbGeAlD
Pimozide—ABCB1—lymph node—acquired immunodeficiency syndrome	9.15e-05	0.00137	CbGeAlD
Pimozide—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.62e-05	0.000325	CbGpPWpGaD
Pimozide—CALM1—Immune System—CCR2—acquired immunodeficiency syndrome	1.61e-05	0.000323	CbGpPWpGaD
Pimozide—CALM2—Immune System—CCR2—acquired immunodeficiency syndrome	1.61e-05	0.000323	CbGpPWpGaD
Pimozide—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000323	CbGpPWpGaD
Pimozide—CALM3—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000323	CbGpPWpGaD
Pimozide—CALM3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000323	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.59e-05	0.00032	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.59e-05	0.00032	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.58e-05	0.000317	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.58e-05	0.000317	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.58e-05	0.000317	CbGpPWpGaD
Pimozide—CALM3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000316	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.57e-05	0.000315	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.57e-05	0.000315	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.56e-05	0.000314	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000312	CbGpPWpGaD
Pimozide—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000312	CbGpPWpGaD
Pimozide—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000312	CbGpPWpGaD
Pimozide—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000312	CbGpPWpGaD
Pimozide—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000312	CbGpPWpGaD
Pimozide—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000312	CbGpPWpGaD
Pimozide—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000312	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.55e-05	0.000312	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.54e-05	0.00031	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000309	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000309	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.54e-05	0.000309	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.54e-05	0.000309	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.53e-05	0.000307	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.53e-05	0.000307	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.53e-05	0.000307	CbGpPWpGaD
Pimozide—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.52e-05	0.000305	CbGpPWpGaD
Pimozide—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.52e-05	0.000305	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.52e-05	0.000304	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.5e-05	0.000301	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	1.5e-05	0.000301	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.47e-05	0.000295	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	1.46e-05	0.000292	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.46e-05	0.000292	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	1.45e-05	0.000292	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.45e-05	0.000291	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	1.45e-05	0.000291	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	1.45e-05	0.000291	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000291	CbGpPWpGaD
Pimozide—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	1.44e-05	0.00029	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000288	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.43e-05	0.000287	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.43e-05	0.000287	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.43e-05	0.000286	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000286	CbGpPWpGaD
Pimozide—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000286	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.42e-05	0.000285	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000284	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000283	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.41e-05	0.000283	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.41e-05	0.000283	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	1.41e-05	0.000283	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	1.41e-05	0.000283	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.41e-05	0.000282	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	1.41e-05	0.000282	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	1.41e-05	0.000282	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.41e-05	0.000282	CbGpPWpGaD
Pimozide—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	1.4e-05	0.00028	CbGpPWpGaD
Pimozide—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	1.4e-05	0.00028	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.39e-05	0.000278	CbGpPWpGaD
Pimozide—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.38e-05	0.000277	CbGpPWpGaD
Pimozide—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.38e-05	0.000277	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.34e-05	0.00027	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.32e-05	0.000266	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.32e-05	0.000264	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.31e-05	0.000262	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.3e-05	0.000261	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.3e-05	0.00026	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.3e-05	0.00026	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.29e-05	0.000259	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.28e-05	0.000257	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.28e-05	0.000256	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.27e-05	0.000255	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.000253	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.000253	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000249	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.24e-05	0.000249	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.24e-05	0.000249	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000248	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000248	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000247	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.000246	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.22e-05	0.000244	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.22e-05	0.000244	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.22e-05	0.000244	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.22e-05	0.000244	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000243	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000242	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.2e-05	0.00024	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.2e-05	0.00024	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.19e-05	0.00024	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.19e-05	0.000239	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	1.18e-05	0.000238	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	1.18e-05	0.000237	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.17e-05	0.000235	CbGpPWpGaD
Pimozide—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	1.17e-05	0.000235	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	1.17e-05	0.000235	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.16e-05	0.000232	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.15e-05	0.000231	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.15e-05	0.000231	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	1.15e-05	0.00023	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	1.15e-05	0.00023	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000229	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000229	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.13e-05	0.000228	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.13e-05	0.000228	CbGpPWpGaD
Pimozide—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000227	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	1.13e-05	0.000227	CbGpPWpGaD
Pimozide—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000227	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	1.13e-05	0.000227	CbGpPWpGaD
Pimozide—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	1.13e-05	0.000226	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000225	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.12e-05	0.000224	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.12e-05	0.000224	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.11e-05	0.000223	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000223	CbGpPWpGaD
Pimozide—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.1e-05	0.00022	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.09e-05	0.00022	CbGpPWpGaD
Pimozide—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.09e-05	0.000219	CbGpPWpGaD
Pimozide—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	1.09e-05	0.000219	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.08e-05	0.000218	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.08e-05	0.000216	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.07e-05	0.000215	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.07e-05	0.000215	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.07e-05	0.000215	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.06e-05	0.000213	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.06e-05	0.000213	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.06e-05	0.000212	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000209	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.04e-05	0.000209	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.04e-05	0.000209	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.03e-05	0.000207	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.01e-05	0.000203	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.01e-05	0.000203	CbGpPWpGaD
Pimozide—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	9.89e-06	0.000199	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.78e-06	0.000196	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.78e-06	0.000196	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.78e-06	0.000196	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.78e-06	0.000196	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.66e-06	0.000194	CbGpPWpGaD
Pimozide—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	9.57e-06	0.000192	CbGpPWpGaD
Pimozide—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	9.57e-06	0.000192	CbGpPWpGaD
Pimozide—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.55e-06	0.000192	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.45e-06	0.00019	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.41e-06	0.000189	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.27e-06	0.000186	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.26e-06	0.000186	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.24e-06	0.000186	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.14e-06	0.000183	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.12e-06	0.000183	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.1e-06	0.000183	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.1e-06	0.000183	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.99e-06	0.00018	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.97e-06	0.00018	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.96e-06	0.00018	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.83e-06	0.000177	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.48e-06	0.00017	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.35e-06	0.000168	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.33e-06	0.000167	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.3e-06	0.000167	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	8.2e-06	0.000165	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.19e-06	0.000164	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.16e-06	0.000164	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.14e-06	0.000164	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.02e-06	0.000161	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.01e-06	0.000161	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.69e-06	0.000154	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.65e-06	0.000154	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.61e-06	0.000153	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.57e-06	0.000152	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.54e-06	0.000151	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.5e-06	0.000151	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.44e-06	0.000149	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.44e-06	0.000149	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.33e-06	0.000147	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.33e-06	0.000147	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	6.97e-06	0.00014	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.93e-06	0.000139	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.78e-06	0.000136	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	6.74e-06	0.000135	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	6.74e-06	0.000135	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	6.73e-06	0.000135	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.7e-06	0.000135	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.7e-06	0.000135	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.55e-06	0.000132	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.55e-06	0.000132	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	6.51e-06	0.000131	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	6.51e-06	0.000131	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.47e-06	0.00013	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.43e-06	0.000129	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.4e-06	0.000129	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.37e-06	0.000128	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	6.25e-06	0.000125	CbGpPWpGaD
Pimozide—CALM3—Disease—CD4—acquired immunodeficiency syndrome	6.21e-06	0.000125	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	6.19e-06	0.000124	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	6.04e-06	0.000121	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	6.04e-06	0.000121	CbGpPWpGaD
Pimozide—CALM1—Disease—CD4—acquired immunodeficiency syndrome	6.01e-06	0.000121	CbGpPWpGaD
Pimozide—CALM2—Disease—CD4—acquired immunodeficiency syndrome	6.01e-06	0.000121	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	5.99e-06	0.00012	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	5.99e-06	0.00012	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	5.94e-06	0.000119	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	5.93e-06	0.000119	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	5.9e-06	0.000119	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	5.71e-06	0.000115	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	5.71e-06	0.000115	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.58e-06	0.000112	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.55e-06	0.000111	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.9e-06	9.84e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.88e-06	9.79e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.82e-06	9.68e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.81e-06	9.66e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.8e-06	9.63e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.79e-06	9.61e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.73e-06	9.5e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.71e-06	9.46e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.58e-06	9.2e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.5e-06	9.03e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.47e-06	8.98e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.43e-06	8.9e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.22e-06	8.46e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4e-06	8.03e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.98e-06	7.99e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.87e-06	7.77e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.87e-06	7.77e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.85e-06	7.73e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.85e-06	7.73e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.8e-06	7.63e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.76e-06	7.56e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	3.64e-06	7.3e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.57e-06	7.17e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	3.52e-06	7.07e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	3.52e-06	7.07e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—acquired immunodeficiency syndrome	3.36e-06	6.74e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.28e-06	6.59e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—acquired immunodeficiency syndrome	3.25e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—acquired immunodeficiency syndrome	3.25e-06	6.52e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.88e-06	5.78e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.83e-06	5.69e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.83e-06	5.68e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.78e-06	5.59e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.76e-06	5.53e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.35e-06	4.72e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.28e-06	4.57e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.28e-06	4.57e-05	CbGpPWpGaD
